about
Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolismAssociation between computed tomography obstruction index and mortality in elderly patients with acute pulmonary embolism: A prospective validation study.Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend studyThe adherence to initial processes of care in elderly patients with acute venous thromboembolismCorticosteroid treatment for community-acquired pneumonia--the STEP trial: study protocol for a randomized controlled trialThe joint influence of gender and amount of smoking on weight gain one year after smoking cessation.Subclinical Thyroid Dysfunction and the Risk of Cognitive Decline: a Meta-Analysis of Prospective Cohort Studies.International variation in GP treatment strategies for subclinical hypothyroidism in older adults: a case-based survey.Multimorbidity and quality of preventive care in Swiss university primary care cohorts.Educational Level, Anticoagulation Quality, and Clinical Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study.Study protocol; Thyroid hormone Replacement for Untreated older adults with Subclinical hypothyroidism - a randomised placebo controlled Trial (TRUST).Uptake and efficacy of a systematic intensive smoking cessation intervention using motivational interviewing for smokers hospitalised for an acute coronary syndrome: a multicentre before-after study with parallel group comparisons.Chronic symptoms in a representative sample of community-dwelling older people: a cross-sectional study in Switzerland.How to prevent overdiagnosis.Echocardiography does not predict mortality in hemodynamically stable elderly patients with acute pulmonary embolism.Thyroid Function Tests in the Reference Range and Fracture: Individual Participant Analysis of Prospective Cohorts.Design of the Swiss Atrial Fibrillation Cohort Study (Swiss-AF): structural brain damage and cognitive decline among patients with atrial fibrillation.Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism.Response to the Letter by Choy.Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study.Pre-hospital alarm activation for STEMI patients undergoing primary percutaneous coronary intervention in the era of transradial procedures.Variation in treatment strategies of Swiss general practitioners for subclinical hypothyroidism in older adults.Development of a core outcome set for medication review in older patients with multimorbidity and polypharmacy: a study protocol.Obesity is not associated with recurrent venous thromboembolism in elderly patients: Results from the prospective SWITCO65+ cohort study.Evidence and controversies regarding the screening for subclinical hypothyroidism in patients with cardiovascular disease.Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts.Frequency of use and acceptability of clinical prediction rules for pulmonary embolism among Swiss general internal medicine residents.Predictors and Outcomes of Recurrent Venous Thromboembolism in Elderly Patients.Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists.Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?Usefulness of D-Dimer Testing in Predicting Recurrence in Elderly Patients with Unprovoked Venous Thromboembolism.Loss of Sirt3 accelerates arterial thrombosis by increasing formation of neutrophil extracellular traps and plasma tissue factor activity.International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy.Omega-3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism.Response to Tomoyuki Kawada, MD: Smoking, Systolic Blood Pressure, Fasting Plasma Glucose and Progression of Carotid Atherosclerosis.New concepts in the management of dyslipidaemiaa.Lessons from the Swiss Medical Board recommendation against mammography screening programs.Low thyroid function is not associated with an accelerated deterioration in renal function.Thyroid Dysfunction and Anemia: A Prospective Cohort Study and a Systematic Review.Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a cross-sectional study.
P50
Q33417203-B8DF931B-FE43-4DE4-A089-F09C46A284A9Q33778707-B41BBB03-8529-4AB3-8265-9B7AA6F20CAEQ33797460-6D490DFA-2E41-4BAC-A81C-DBB65AEA71FCQ33830642-7F8E6846-E053-4918-B3AD-4FFFFDA4C2FCQ33853198-9ADDF7EA-7328-4DDE-BB67-22BEFADC346CQ34086187-338F2990-0321-4EAB-892B-8EC3F88A7112Q34541613-F37DC091-100B-4592-B401-887C4D7A7229Q35076011-3E3D800E-C364-4D7F-B980-B8711055CF06Q35156287-294EF313-8BC6-42F9-AF40-210E8C684E8DQ36126175-A87BF07C-0C7C-40D5-9412-E7FD2430A0D9Q36270288-F31F5598-7408-4C2C-AFAF-AC99A7319EFEQ37312351-06DD4D39-90EC-4402-BE4F-AA5CA4C544BAQ37598209-C3C8A005-7C59-4E2A-B605-5F36BC788357Q38328580-A6A2AB3B-C321-4219-88C6-7BA2DBFE0A2CQ38389134-F98C79BF-4988-4EBB-A2CB-627B2C725CF7Q38798082-D3F0EA92-C309-4CFC-8054-D56E1DA69509Q40127870-F5A172C0-4CF6-46D6-811C-6722CDA5A8FAQ40246242-3A8003A9-75CB-413D-9A4B-5A9B97126711Q40252956-9755E4BC-F6CE-4B23-B855-CC9540FC1C8AQ40506524-BE1DD179-C2AA-4BBF-97A7-861431E0CA21Q40642564-E440E8BD-C180-4929-BC6D-52315ECB5956Q40686409-C670BDF0-31B3-45A6-BE79-136F4AA806B0Q41632588-CC77A468-6C98-4121-AE23-A882852D0B52Q41702785-BF8D98A3-ED42-46CB-A088-994601187582Q42068703-372E87E5-2D07-49E2-962E-023113D2A21DQ46074511-68E6972A-37FC-46E0-B916-8D79346F9EE1Q47231374-FC2065A1-8D5C-49B8-ABAF-9A78376EC83EQ47564368-4B0B62C6-9D3D-44EC-9ADC-9177903A6BF1Q47728750-7BE79361-AEA8-4BAD-B642-BF585EB6BDDAQ47826895-F4E76B77-D5D3-4532-A0B3-06AA8BD6330AQ47864758-CB5B3EF7-76B1-47C7-9BCC-E028B0884AA4Q49999953-B2FCF665-564F-4271-BB6F-EAE0F7F1D3E7Q50042913-7B2070C8-EB2A-4C43-B7AA-473C9DBF0E99Q50129776-189B3E2C-4093-4D02-AA7F-4F5E93A175ADQ51279377-B671DA1A-B4BD-49B6-A4AA-04040F89105BQ51308624-E1587519-946D-41EC-848F-38B1DF6FCD6BQ51797920-59BC0228-97D8-44AD-940F-27F07557A33BQ52569939-CF499C8B-A5E7-42B9-9CF6-DA600BDD8F9DQ52598282-C9E2051D-714B-4A69-94E9-99560E7D4B91Q53835712-66E45A3C-552F-4FE6-B80A-4A62276AD912
P50
description
researcher
@en
name
Nicolas Rodondi
@en
type
label
Nicolas Rodondi
@en
prefLabel
Nicolas Rodondi
@en
P31
P496
0000-0001-9083-6896